Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis Minimal Lesion

Explore clinical trials studying Glomerulonephritis Minimal Lesion. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Glomerulonephritis Minimal Lesion trial results

Recruiting

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

NCT06500702

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +10 more
Locations
  • Investigational Site Number : 8400007 Birmingham, Alabama, United States
  • Investigational Site Number : 8400015 Orange, California, United States
  • Investigational Site Number : 8400012 San Francisco, California, United States
  • Investigational Site Number : 8400025 Tampa, Florida, United States
View all 71 locations
View Trial Details

Related conditions